Weak third quarter at Evonik
In an environment of high uncertainty and weak demand, Evonik generated adjusted EBITDA of €448 million in the third quarter of 2025 ─ 22 percent below the robust prior-year results (Q3 2024: €577 million) and within the expected range of €420 million to €460 million as communicated on September 25. ... MORE